Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Solid Tumor 3Lung Neoplasms 3Breast Neoplasms 3Glioma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Oncologic Diseases 1Neurotoxicity Syndromes 1Melanoma 1Liver Cirrhosis 1Glioblastoma 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Temozolomide 12Magnetic Resonance Spectroscopy 9Radiotherapy 6Surveys and Questionnaires 5Blood Specimen Collection 4Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Radiation 3Perfusion Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Lomustine 2Immunotherapy 2Drug Therapy 2Chemoradiotherapy 2Amplified Fragment Length Polymorphism Analysis 2regorafenib 1lentiviral minigene vaccine of COVID-19 coronavirus 1gadodiamide 1apatinib 1Ultrasonography 1Trail Making Test 1Therapies, Investigational 1Tablets 1Standard of Care 1Specimen Handling 1Sampling Studies 1Re-Irradiation 1Quality of Life 1Psychometrics 1Proton Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Glioblastoma × Fluorodeoxyglucose F18 × Clear all
NCT02919332 2020-07-24

Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma

Jonsson Comprehensive Cancer Center

Withdrawn
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡